Literature DB >> 6433509

Liver, kidney, and central nervous system toxicity of aluminum given intraperitoneally to rats: a multiple-dose subchronic study using aluminum nitrilotriacetate.

Y Ebina, S Okada, S Hamazaki, O Midorikawa.   

Abstract

In the first test, aluminum nitrilotriacetate (Al-NTA), aluminum chloride, aluminum potassium sulfate, or saline was injected ip, employing male Wistar rats. Each group consisted of ten rats. Al was given in a dose of 5 mg Al/kg body wt/day, for 14 days. Only those rats given Al-NTA showed morphological damage of the liver and kidney. Damages included diffuse midzonal coagulation necrosis of hepatocytes and acute proximal tubular necrosis of the kidney at Day 4. Seven of ten rats given Al-NTA died within 5 days. The second test was performed in metabolic cages. Al-NTA, in a dose of 1.5 to 2.0 mg Al/kg body wt/day, and NTA, of an equivalent dose, were injected ip for 54 days. Midzonal coagulation necrosis and some regenerative changes were observed in the hepatic parenchyma at Day 8. At the end of the study, complete regeneration occurred in the liver. Biochemical tests at Days 6, 13, and 28 showed high amounts of GOT, GPT, LDH, gamma-GTP, and ALP. Necrosis of proximal tubular cells of the kidney and some regeneration was noted at Day 8. Metabolic acidosis was demonstrated at Days 6, 13, and 28. Moreover, from Day 38 on, atrophy of the nerve cells of the cerebrum and demyelination of the brain stem were observed. Control rats given NTA did not exhibit any organ damage. It is concluded that a relatively small dose of Al can produce toxicosis when given with certain metal chelators.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6433509     DOI: 10.1016/0041-008x(84)90203-5

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Similar effects in vivo of two aluminum salts on the liver, kidney, bone, and brain of Rattus norvegicus.

Authors:  A K Roy; G Talukder; A Sharma
Journal:  Bull Environ Contam Toxicol       Date:  1991-08       Impact factor: 2.151

3.  Distribution of aluminum in different brain regions and body organs of rat.

Authors:  D Julka; R K Vasishta; K D Gill
Journal:  Biol Trace Elem Res       Date:  1996-05       Impact factor: 3.738

4.  Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes.

Authors:  Y Ebina; S Okada; S Hamazaki; Y Toda; O Midorikawa
Journal:  Calcif Tissue Int       Date:  1991-01       Impact factor: 4.333

5.  Cirrhosis of the liver induced by cupric nitrilotriacetate in Wistar rats. An experimental model of copper toxicosis.

Authors:  S Toyokuni; S Okada; S Hamazaki; M Fujioka; J L Li; O Midorikawa
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

6.  Transforming growth factor-alpha expression of renal proximal tubules in Wistar rats treated with ferric and aluminum nitrilotriacetate.

Authors:  J Deguchi; T Kawabata; A Kondo; S Okada
Journal:  Jpn J Cancer Res       Date:  1993-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.